Research Article Usage of EMBRACETM in Gujarat, India: Survey of Paediatricians

Copyright © 2014 Somashekhar Nimbalkar et al.This is an open access article distributed under theCreativeCommonsAttribution License, which permits unrestricted use, distribution, and reproduction in anymedium, provided the originalwork is properly cited. Aim. EMBRACETM is an innovative, low cost infant warmer for use in neonates. It contains phase change material, which stays at constant temperature for 6 hours. We surveyed paediatricians using EMBRACETM regarding benefits, risks, and setup in which it was used in Gujarat.Methods. Questionnaire was administered telephonically to 52 out of 53 paediatricians. Results. EMBRACETM was used for an average of 8.27 (range of 3–18, SD = 3.84) months by paediatricians. All used it for thermoregulation during transfers, for average (SD) duration of 42 (0.64)m per transfer, 62.7 % used it at mother’s side for average (SD) 11.06 (7.89) h per day, and 3.9 % prescribed it at home. It was used in low birth weight neonates only by 56.9 % while 43.1 % used it for all neonates. While hyperthermia was not reported, 5.9 % felt that EMBRACETM did not prevent hypothermia. About 54.9 % felt that they could not monitor the newborn during EMBRACETM use. Of paediatricians who practiced kangaroo mother care (KMC), 7.7 % have limited/stopped/decreased the practice of KMC and substituted it with EMBRACETM. Conclusions. EMBRACETM was acceptable to most but concerns related to monitoring neonates and disinfection remained. Most paediatricians felt that it did not hamper KMC practice. 1